Chimerix Inc (NASDAQ:CMRX)

1.83
Delayed Data
As of Sep 23
 -0.07 / -3.68%
Today’s Change
1.27
Today|||52-Week Range
7.42
-71.54%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$159.9M

Company Description

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.

Contact Information

Chimerix, Inc.
2505 Meridian Parkway
Durham North Carolina 27713
P:(919) 806-1074
Investor Relations:

Employees

Shareholders

Other institutional42.01%
Mutual fund holders15.85%
Individual stakeholders15.52%

Top Executives

Michael A. ShermanPresident, Chief Executive Officer & Director
Michael T. AndrioleChief Financial & Business Officer
Randall LanierChief Scientific Officer
Roy W. WareChief Technology & Manufacturing Officer
Caryn BarnettVice President-Clinical Operations